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ABSTRACT
According to Blumrosen et al. (2020), the dialysis population cost expenditure is
greater than “seven percent of the Medicare budget at nearly $40 billion a year” even
though this population is “less than one percent of the Medicare population” (p. 1436).
Additionally, the renal disease population is growing in the United States and
internationally which contributes to rising healthcare costs around the globe (Levin,
2018).
The purpose of this Doctor of Nursing Practice (DNP) project was to identify the
factors or reasons hemodialysis patients miss treatments or only stay for partial treatment.
Hemodialysis patients are required to have treatments three times weekly. However,
hemodialysis patients have a high incidence of missed or shortened treatments. The
patient population who misses treatment are at risk of poor outcomes such as fluid
overload, hospitalizations, and mortality.
Depression may be the reason for missed treatments. The retrospective
quantitative review was conducted on each patient if they missed one or more treatments
in a four-month window (Al Salmi et al., 2018). The practitioner-researcher collected
data in the retrospective review to ascertain depression scores, previous treatments, or
previous mental health treatment. The DNP researcher was searching to find the answer
to improve this patient population outcomes.
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CHAPTER I - INTRODUCTION
Diabetes is the leading cause of the end-stage renal disease (ESRD) in the United
States and in “most countries around the world” (Snider et al., 2019). The cost of
Medicare treatment for ESRD is more than 32 billion annually (Ahmadmehrabi & Tang,
2018). Additionally, the amount of people with ESRD in the United States is staggering.
According to Sullivan et al. (2019), almost 700,000 patients are undergoing renal
replacement therapy. Also, according to the Centers for Disease Control and Prevention
(CDC, 2021), the number of adults in the United States with chronic kidney disease
(CKD) is greater than one in seven people; furthermore, nine out of ten patients with
CKD do not know the disease is present and have no symptoms (CDC, 2021).
Consequently, 131,600 people progressed to ESRD and began treatment in 2018 (CDC,
2021). The ethnic adult percentages affected by CKD are 16% African American, 14%,
Hispanic, 13% Asian, and 13% Caucasian (CDC, 2021).
ESRD is defined as usually slow but irreversible damage to the kidney that
continues until kidney function is decreased and no longer able to remove toxins and
fluid from the body “which may lead to high blood pressure” (CDC, 2021, p. 1). Diabetes
is the major cause of ESRD; however, other causes are heart disease, hypertension,
obesity, hereditary, and prior kidney damage. CKD has five stages of progression hence
the fifth and final stage of chronic kidney disease in ESRD.
ESRD requires renal replacement therapy to sustain life. Patients choose their
renal replacement therapy after education regarding the choices. The choices include incenter hemodialysis, home hemodialysis, and home peritoneal dialysis. In 2018, the
incidence rate of end-stage renal disease grew by 2.3% to a total of 131,636 people from
1

the previous year; the number of people choosing hemodialysis at the hemodialysis
outpatient unit increased to 113,000 (U.S. Renal Data System (USRDS), 2020).
Hemodialysis patients who miss treatments have an increased risk for
hospitalization, inadequate dialysis, and cardiac complications. The mortality rate for
hemodialysis patients was “192.9 per thousand patient-years in 2009 but decreased to
164.4% in 2018” (USRDS, 2020, p.1). However, most deaths for ESRD patients are due
to cardiovascular disease with associated arrhythmias and sudden cardiac arrest
(Ahmadmehrabi & Tang, 2018).
Background
The ESRD population is an intricate group of patients with multiple comorbidities. The hemodialysis patient may have diabetes, hypertension, heart disease,
anemia, secondary hyperparathyroidism, previous stroke, depression, and thyroid disease.
In addition, hemodialysis patients may have multiple medications for each comorbidity
such as three or more blood pressure medications, three or four phosphorus binders as
well as other medications for comorbidities. The hemodialysis patients have many
lifestyle changes, for example, dietary restrictions, fluid restrictions and travel to the
dialysis unit three times weekly.
The fluid restrictions are 40 ounces of fluid a day which includes any fluid or
food that melts. High potassium foods are limited because high serum potassium may
cause irregular heart rhythm which can lead to hospitalization or death. For example, a
list of some of the foods to avoid are oranges, bananas, milk, watermelon, tomatoes, nuts,
dried foods, etc. In addition, foods high in phosphorus are also limited. The only cola that
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patients can drink is sprite or clear cola and the only dark cola is “Barque’s” root beer
due to the high phosphorus content in the other dark colas.
Hemodialysis patients are required to have hemodialysis treatments three times
weekly for an average of three to five hours in dialysis treatment. A portion of
hemodialysis patients is noncompliant with their dialysis treatments. The dialysis
treatment missed may be one of the three treatments weekly or signing off early from
their three weekly treatments. The hemodialysis patients are also non-compliant with
medications including phosphorus binder medication and medication to treat secondary
hyperparathyroidism. The patient population has a complex self-care regime and multiple
restrictions which is life-changing and maybe part of the reason for missed treatments.
Furthermore, according to Pena-Polanco et al. (2017), 25% of hemodialysis
patients frequently have depression. Hemodialysis patients undergo life changes such as
possible job loss which results in the loss of insurance and possible health decline which
requires family support. (Pena-Polanco et al., 2017). Also, hemodialysis patients may
develop side effects with the phosphorus binder which is needed to reduce phosphorus in
the blood. Finally, the dialysis treatment can cause cramps and weakness after the session
which may contribute the patients to hopelessness regarding life changes.
Significance
Noncompliance with hemodialysis treatments is a powerful indicator of
unfortunate outcomes with ESRD patients. The hemodialysis population has an increased
occurrence of hospitalizations at “1.73 per patient-year” which is two times higher in
comparison to other chronic diseases with comparable “age groups and comorbidities as
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well as readmission rates at 35%” (Blumrosen et al., 2020, pp. 1435-1436). Hemodialysis
removes metabolic wastes from the body.
However, when patients are noncompliant with dietary restrictions and gain
excessive fluid between treatments, the process of hemodialysis or the elimination power
must increase to remove the toxic waste. As a result, according to Wang et al. (2017),
“bone demineralization, pulmonary edema, metabolic disorder, cardiovascular damage”
(p. 102) can occur. Patients who miss dialysis treatments also risk poor outcomes due to
inadequate dialysis.
According to the USRDS (2020), the prevalence of ESRD was 3.4 times higher in
African Americans than Caucasian people. Furthermore, the prevalence of African
Americans undergoing hemodialysis at the outpatient dialysis units was 72% compared to
57% Caucasian people on hemodialysis at the outpatient dialysis units (USRDS, 2020).
Caucasian people on hemodialysis have higher mortality rates than African Americans on
hemodialysis (USRDS, 2020). ESRD cause mortality was attributed to
“arrhythmia/cardiac arrest or sudden cardiac death by 44.2% in 2018” (USRDS, 2020, p.
11).
Depression is prevalent in the ESRD population. Depression is also a contributing
factor for noncompliance with hemodialysis treatments (Pena-Polanco et al., 2017). In
addition, ESRD patients with multiple co-morbidities have decreased health status.
(Pena-Polanco et al., 2017). This population of patients have decreased appetites, and
many have low albumins which contribute to their decreased health. Thus, the provider
will add a new medication for appetite however, the new medication adds to the plethora
of medications the population has to take daily.
4

Problem Statement
The purpose of this project was to create and implement a project that was
evidenced based to ascertain the answer for improving compliance with dialysis patients.
Hemodialysis patients have a complicated treatment plan that has many restrictions. The
restrictions have recurrent episodes of noncompliance. Improving noncompliant patient
compliance is the goal with hemodialysis treatments. Equally important for hemodialysis
patients was decreased hospitalizations due to fluid overload. Therefore, healthcare cost
is decreased which in turn decreases the risk for poor outcomes for the patient population.
Hemodialysis is required three times weekly to remove fluid and waste. The incenter hemodialysis patients are connected to a machine to clean the patient’s blood
through a dialysis filter that mimics the kidney. In contrast, normal kidneys in a patient
work daily cleaning the patients’ blood automatically. As a result, non-compliant patients
are at risk of poor outcomes even if only one hemodialysis treatment is missed due to
inadequate dialysis. This Doctor of Nursing Practice (DNP) was focused on addressing
the question to find out if depression was the reason for missed dialysis treatments, or do
patients miss dialysis treatments due to behavior patterns.
Available Knowledge
“Non-adherence is highly prevalent among chronic hemodialysis patients and is
associated with poor quality of life, depression, and malnutrition” (Ibrahim et al., 2015,
p.1). The hemodialysis patients gain knowledge through educational interventions to
improve compliance; however, the behavior change only lasts for a short time frame
before reoccurrence (Murali et al., 2019).

5

PICO
Among hemodialysis patients who are non-compliant with hemodialysis
treatments (P), how does treatment for depression affect compliance with dialysis
treatments (I) compared to hemodialysis patients who do not have treatment for
depression (C) will have improved compliance with treatments (O).
Needs Assessment
According to Salim et al. (2018), the incidence rate for hemodialysis patients in
Mississippi was 1,682 in 2016. “Blacks have a fourfold prevalence rate of hemodialysis
treatments” which is more than Caucasians (Blumrosen et al., 2020, p.1435). The adult
hemodialysis in center units includes patient ages between 18 and 95 years old. The
poverty rate is high in Mississippi (Salim et al., 2018). In addition, some patient
insurances do not cover all the medication prescribed or may cover the required
medication, but the copay is too expensive. A few of the reasons possibly associated
with missed treatments include “heavy pill burden, lower socioeconomic status,
depression, and poor health literacy (Murali et al., 2019 p. 20).
According to Al Salmi et al. (2018), among hemodialysis patients in the United
States, 20-24% of the patients missed one or more of their treatments. Noncompliant
patients are in all ten hemodialysis units. The hemodialysis patients missing one
treatment in a “four-month window are at risk poor outcomes according to the missed
treatment risk >5%”, (Al Salmi et al., 2018 p. 634). Consequently, this population of
hemodialysis patients have an increased risk of death or hospitalization.
Depressive symptoms are also frequently found in the hemodialysis population.
According to Nadort et al. (2019), the symptoms do not resolve without treatment.
6

Therefore, the depressive symptoms can also contribute to missed dialysis treatments
(Nadort et al., 2019). Depressed symptoms can decrease happiness, and wellbeing for this
population because of the life changes associated with ESRD on hemodialysis (Nadort et
al., 2019).
Synthesis of Evidence
An electronic database search was performed to find articles for the DNP project
in CINAHL, EBSCOhost, Medline, Consumer Health Complete, Google Scholar,
Science Direct, Psych Behavior Sciences, and the Cochrane Library. The search
parameters included noncompliance or nonadherence, hemodialysis treatments. Other
search criteria included depression, chronic kidney disease, hemodialysis, end-stage renal
disease. Filters were utilized for full-text articles, peer-reviewed articles, and the English
language.
The initial search revealed 15,622 articles. Therefore, articles were discarded if
involving pediatric patients or patients under eighteen as well as any articles not related
to the project which narrowed the number down to1,436. In addition, the articles were
saved if the articles revealed insight into factors related to noncompliance or outcomes to
noncompliance in hemodialysis. Articles were reviewed for evidence-based practice and
interventions to improve compliance with hemodialysis patients. The articles were
narrowed down to 50. Finally, the articles were narrowed to the geography filter for the
United States or the US thus African Americans would be included in the studies. The
total number of articles used was 16. The following reveals the synthesis of evidence.
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Systematic Review
According to Murali et al. (2019), a few of the reasons possibly associated with
missed treatments include “heavy pill burden, lower socioeconomic status, depression,
and poor health literacy” (p. 20). The interventions' first article is a systematic review and
analysis with four different interventions to synthesize. The first intervention is
educational/cognitive” which explains the reasons for compliance with dialysis
treatments to the patient population; the second intervention is “counseling/behavioral”
which focuses on the attitudes and the abilities of the patient population to take charge of
their own health (Murali et al., 2019, p. 4).
The third intervention is “psychologic/affective” which focuses on the patient
population’s reactions to social underpinning (Murali et al., 2019, p. 4). The final
intervention is “mixed interventions” which combines different interventions to find
improvement to compliance (Murali et al., 2019, p. 4). Additionally, many behavior
theories were used in the randomized trials (Murali et al., 2019).
The Cochrane Risk Bias Tool and PRISMA checklist were used in the review and
analysis of randomized controlled trials (Murali et al., 2019). In addition, the
randomized analysis revealed an insufficiency of uniform compliance measures pre- and
post-intervention which may cause “variations in adherence” (Murali et al., 2019, p. 3).
In addition, some trials had a lower number of participants included in the randomized
trials which may increase the risk of selection bias regarding adherence (Murali et al.,
2019).
Finally, the results of the study analysis revealed the interventions improved
compliance for a short period, then a recurrence of noncompliance returned (Murali et al.,
8

2019). In addition, the “education intervention did not translate” into long-term
compliance. However, according to Murali et al. (2019), cognitive behavioral therapy
may be the best hope in this patient population.
Systematic Review
In contrast, according to Tao et al. (2020), compliance with dialysis treatments is
a partnership between the patient and the provider. Similarly, to the previous study, the
interventions were “cognitive behavioral therapy as well as counseling, family support,
and educational interventions” (p. 2835). In contrast, the study was focused on one
combined intervention “psycho-social and educational” (Tao et al., 2020 p. 2835). In
comparison to prior article synthesis, the intervention analysis revealed improved
compliance in treatment by focusing on one individual at a time (Tao et al., 2020). The
intervention was adjusted for each patient by talking to the patient one-to-one during an
educational session resulted in improved compliance outcomes (Tao et al., 2020).
Similarly, the PRISMA guidelines were used in the review and analysis of the
randomized trials in the study. According to Tao et al. (2020) risk of bias was found in
some of the reviews in the study. However, publication bias was not identified due to the
“funnel plots” (Tao et al., 2020, p. 2840).
Systematic Review
Similarly, according to Blumrosen et al. (2020), the patients’ reasons for
noncompliance were transportation, weather, and behavior patterns. Three interventions
were used in the study. Similarly, to the previous study “therapeutic alliance” was used in
the interventions to engage the African Americans through an agreement between the
“patient and the provider” to establish the goals and behavior to choose the desired
9

intervention (Blumrosen et al., 2020, p. 1436). The first intervention was “automated
messaging” which included a text or phone message three times weekly to remind noncompliant patients to go to dialysis treatment however no theory was associated with the
intervention (Blumrosen et al., 2020, p. 1440).
The second intervention was “improving patient experience” using diffusion-of
innovation-theory and a multidisciplinary team care approach with a questionnaire at the
beginning and end of the intervention to obtain information regarding patient satisfaction
(Blumrosen et al., 2020, p. 1440). The third intervention was focused on combining a
compliant patient with a non-compliant patient using social cognitive theory for “peer to
peer for a quality improvement program through positive feedback and rewarding”
(Blumrosen et al., 2020 p. 1439). All three interventions may improve treatment
compliance except leaving dialysis early or stopping before prescription time is
completed (Blumrosen et al., 2020).
In comparison to all the previous studies in this analysis, the systematic review
inclusion criteria were specific and included only studies with more than 25% African
Americans and specific designs “quasi-experimental and experimental” (Blumrosen et
al., 2020, p. 1437). Only three studies were used for synthesis with one randomized trial
and two pre-post single-armed intervention studies which may increase the risk of bias
(Blumrosen et al., 2020, p. 1437). However, according to (Blumrosen et al. (2020), all
three interventions may improve compliance.
Depression Study in Veterans
Similarly, according to Pena-Polanco et al. (2017), the hemodialysis patient
population has many “symptoms, of which depression is particularly common, affecting
10

up to 25% of the patients” p.298). The hemodialysis patients may show benefit from
“antidepressant medication and cognitive behavioral therapy” (p.298). A clusterrandomized trial evaluated five interventions (Pena-Polanco et al., 2017, p. 299). In
contrast to previous studies, this study was done at a Veterans Center with African
American men.
Depression scores were obtained monthly for approximately one year. Five
interventions were offered to the patients with a positive Patient Health Questionnaire
(PHQ-9) score (Pena-Polanco et al., 2017). The first intervention was increasing the dose
of current medication; the second intervention was prescribing a different medication
(Pena-Polanco et al., 2017). The third intervention was prescribing a depression
medication, or a second medication was started; the fourth intervention was referring the
patient to a mental health professional or setting up a follow-up appointment with the
mental health professional (Pena-Polanco et al., 2017).
However, the hemodialysis population may refuse treatment with depression
medications or referral to mental health facility even with positive (PHQ-9) scores (PenaPolanco et al., 2017). The results of the trial were astounding, seventy-seven percent of
the trial participants would not accept any treatment for depression. Furthermore, some of
the depression medications may not be effective in hemodialysis patients (Pena-Polanco
et al., 2017).
African American Perspective
Similarly, according to Haynes et al. (2017), African Americans are generally
resistant to accepting mental health treatment than other “racial and ethnic groups in the
rural South” (p. 573). The barriers to treatment are “stigma of mental health, and low
11

mental health literacy” (Haynes et al., 2017, p. 577). In contrast, the participants in the
qualitative study were mostly African American women who recommended three
interventions to help with mental health which was “increasing social support, improving
mental health literacy and promoting emotional wellness” (Haynes et al., 2017, p. 573).
Other barriers are “mistrust and fear of treatment” (Haynes et al., 2017, p. 573).
According to Haynes et al. (2017) in contrast, the barriers may improve by using
telemedicine for mental health treatment which would keep the participant anonymous
(Haynes et al., 2017, p. 573). Additional similar barriers are “social inequities, racism,
unemployment and poverty” which may contribute to depression (Haynes et al., 2017, p.
576).
Dialysis Outcome Study
According to Al Salmi et al. (2018), hemodialysis patients who are non-compliant
with hemodialysis treatments were studied in a prospective observational study. The
study included four hemodialysis in-center units in the United States for compliance; a
comparison study was done in Japan, Sweden, and multiple other countries (Al Salmi et
al., 2018). In comparison, the results of the study revealed the most compelling finding
was mortality detected in the noncompliant patients with only one treatment missed in
four months (Al Salmi et al., 2018).
Furthermore, the patients had more hospital visits and emergent visits due to noncompliance (Al Salmi et al., 2018). Similarly, some of the reasons patients did not go to
dialysis treatment were health literacy, young patients, and transportation (Al Salmi et al.,
2018). Out of twenty countries in the study, the United States had the most amount of
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noncompliance and increased risk in comparison to the other nineteen countries in the
study (Al Salmi et al., 2018).
Induced Cardiac Risk
According to Ahmadmehrabi and Tang (2018), the cardiac risk is increased in the
ESRD population. Like previous studies, the hemodialysis population has high mortality
due to cardiac complications (Ahmadmehrabi & Tang 2018). The cardiac issues may be
caused by several factors. ESRD patients are lacking in erythropoietin which causes
anemia (Ahmadmehrabi & Tang, 2018).
Consequently, “anemia promotes cardiac ischemia” (Ahmadmehrabi & Tang,
2018, p. 259). Other factors associated with cardiac complications in hemodialysis
patients are chronic volume overload, and platelet abnormalities (Ahmadmehrabi &
Tang, 2018). As a result, left ventricular hypertrophy can also increase the risk of cardiac
ischemia (Ahmadmehrabi & Tang 2018).
According to Wang et al. (2017), the meta-analysis of nursing interventions was
reviewed to evaluate for improved compliance with treatments. The interventions were
behavioral, educational, and cognitive like previous studies in this paper (Wang et al.
(2017). However, the measures were not consistent resulting in difficulty to replicate
Wang et al. (2017). Additionally, the other interventions were not found to have
significant differences (Wang et al., 2017).
Benefits of Home Hemodialysis
According to Salim et al. (2018), the hemodialysis in center units in Mississippi
has a large population of patients. However, the home hemodialysis population is only
2% in Mississippi. (Salim et al., 2018). The benefits of home hemodialysis are dialysis
13

treatments every day which may decrease left ventricular hypertrophy and mortality
(Salim et al., 2018). Mississippi is a rural state with a large population of people living in
poverty. In comparison, noncompliance reasons are “impaired quality of life, depression,
and post dialysis fatigue” (Salim et al., 2018, p. 80).
Diabetic Kidney Disease
According to Snider et al. (2019), this study was done to check the effectiveness
of a biomarker to obtain an early diagnosis of Diabetic kidney disease (DKD). “DKD is a
complication from diabetes” (p. 2). Patients with diabetes and ESRD have a “4.5 times
mortality risk than diabetes alone” (Snider et al., 2019, p. 2). The biomarker was found to
be effective in diagnosing DKD earlier, therefore DKD progression could be decreased
(Snider et al., 2019).
Cluster-Randomized Controlled Trial
According to Snider et al. (2019), this study was done to check the effectiveness
of a biomarker to obtain an early diagnosis of Diabetic kidney disease (DKD). “DKD is a
complication from diabetes” (p. 2). Patients with diabetes and ESRD have a “4.5 times
mortality risk than diabetes alone” (Snider et al., 2019, p. 2). The biomarker was found to
be effective in diagnosing DKD earlier, therefore DKD progression could be decreased
(Snider et al., 2019).
Improving Global Kidney Expert Opinion
According to Levin, (2018), the prevalence of chronic kidney disease is creating a
large burden throughout the world due to the increasing incidence of chronic kidney
disease. Therefore, a conference was held for the global experts to discuss ways to
improve CKD outcomes (Levin, 2018). Nephrologists and other experts collaborate for
14

the improvement of kidney treatment. A meeting was coordinated to research and explore
to “improve global kidney health” (Levin, 2018).
Social Determinants of Health
Non-English-speaking patients on hemodialysis have cultural language barriers.
The plan of care is discussed through an interpreter or family member with the patients’
permission. Health literacy is also a barrier for patients living in poverty and decreased
education. Mental health literacy is also a barrier to care in African Americans. The
dialysis population is impacted by cultural disparities and decreased access or gap in care.
One example of a gap in care is mental health care. Dialysis patients are not
accepted at some mental health centers locally due to insurance. The dialysis patients can
be seen at county facilities on a first-come basis, stand in line then show insurance
information. At this point, the mental health center will set up an outpatient appointment
for a later date.
However, transportation can be a barrier for mental health treatment with
hemodialysis patients seeking care because of transportation issues. Patients must travel
sometimes 30 minutes or an hour to the mental health facility. The second appointment is
for the history and evaluation. The third trip is for the appointment with the provider,
which means the patients may travel and pay for transportation three times before they
see a provider.
Patients who live in rural areas have difficulty with transportation to and from
dialysis. The dialysis treatment centers are in the rural areas of Mississippi; however,
some patients still may travel 20 to 30 minutes to the dialysis center. Patients who do not
qualify for transportation services rely on family for transportation. Furthermore, some
15

patients have transportation for dialysis but not for appointments that are not related to
dialysis. As a result, appointments for counseling are difficult due to transportation unless
the family takes the patient to the appointments.
Rationale
The synthesis evidence supports adequate evidence to correlate with depression as
the cause of noncompliance in hemodialysis patients. The hemodialysis patient
population is at risk of poor outcomes due to missing only one treatment in four months
(Al Salmi et al., 2018). Finding the best intervention to treat the patients with depression
may decrease noncompliance. This patient population has an increased risk for
hospitalization and mortality due to missing dialysis treatments.
The research synthesis did reveal multiple interventions for noncompliance. The
interventions were similar, and some were repetitive but overall did not show the best
evidence. Compliance measures are lacking in African American or Black Americans in
the United States. The African American or Black American patient population needs
more evidence to decrease the noncompliance in the hemodialysis patients.
Theoretical Framework
Social Cognitive Theory (SCT) was the framework for this DNP project. Albert
Bandura developed SCT in the mid-1970s (Middleton et al., 2018). SCT explains how
patients have a constant relationship between the “individual and the environment”
(Adefolalu, 2018, p. 2). The premise of “cognitive theory is learning” in addition,
behavior is developed by “social acquisition of knowledge” (Adefolalu, 2018, p.2).
Patients can create change by controlling the way they behave with thought processes and
actions (Adefolalu, 2018).
16

The four ways to influence self-efficacy are performance mastery and is defined a
strategic plan to do away with negative thinking in exchange for positive thoughts to
reinforce the need for compliance (Adefolalu, 2018). Vicarious experience is defined as
compliance with treatments after witnessing a reward given to another patient for
compliance with treatment (Adefolalu, 2018). Verbal persuasion is defined as the patient
maintains compliance in the long run by positively reinforcing compliance (Adefolalu,
2018). Physiological symptoms are defined as reactions associated with patients such as
difficult situations, stressors, or other social determinants of health that may increase the
risk of non-compliance with treatments (Adefolalu, 2018, p. 2).
According to Adefolalu (2018), self-efficacy is influenced by a desire to be
compliant with treatments for change to occur (Adefolalu, 2018). However, if the patient
does not desire change, then patients are not sure compliance is possible (Adefolalu,
2018). The behavioral theory of compliance is reinforced by a reward or praise from by a
provider.
Specific Aims
This DNP project was focused on addressing the question to find out if depression
is the reason for missed dialysis treatments. A quantitative retrospective review was
obtained on previous treatments or no treatment for depression. Thus, research for
evidence-based interventions was used in the previous treatment of depression compared
to no treatment of depression. The measurable objection was improved compliance with
hemodialysis treatments with depression treatment. In addition, the practitionerresearcher used a data collection tool to obtain measurable outcomes from previous
treatments for depression.
17

DNP Essentials
Four DNP Essentials were a priority and aligned with this project. The DNP
essentials were I, III, VI, and VII (American Association College of Nursing [AANC],
2017).
DNP Essential I is Scientific Underpinnings for practice. This essential allowed
incorporation of nursing science as a framework for the project through the social
cognitive theory. Social cognitive theory encourages the patient to be proactive in selfhealth care which will strengthen healthcare delivery and outcomes (AANC, 2017).
DNP Essential III is Clinical Scholarship and Analytical Methods for
Evidence-based Practice. The DNP program increased knowledge for ascertaining the
best evidence-based practice. Leadership skills were used to implement and translate
evidence-based research into practice and improve outcomes for the patient population
(AANC, 2017).
DNP Essential VI is Interprofessional Collaboration for Improving Patient and
Population Health Outcomes. The DNP graduate developed leadership and collaborative
skills. Therefore, the DNP graduate used the skills to enhance the interprofessional
partnership for the patient population (AANC, 2017).
DNP Essentials VII is Clinical Prevention and Population Health for Improving
the Nation’s Health. The DNP graduate was searching for evidence-based interventions
to increase outcomes for the hemodialysis patient population. The DNP researcher was
searching to find the evidence to decrease gaps in care and improve the patient population
and overall health (AANC, 2017).
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Summary
The synthesis of evidence revealed several interventions as well as inequities for
noncompliance with the hemodialysis patient population. The literature review revealed
depression and depressive symptoms for this patient population. The retrospective chart
review of interventions did yield more evidence for depression treatment. Consequently,
the evidence can improve outcomes for the population.
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CHAPTER II - METHODOLOGY
Introduction
The DNP project was performed to find the evidence-based intervention for
compliance. The outpatient hemodialysis patients missed hemodialysis treatments or
skipped part of the three times weekly dialysis treatments. The DNP student researcher
investigated to see if depression was the cause of non-compliance with the hemodialysis
treatments at the outpatient dialysis units. In addition, the investigator reviewed previous
depression measures found in the retrospective chart review.
Hemodialysis patients who missed one or more of the three times weekly required
hemodialysis treatments in four months were at risk for poor outcomes. In addition, the
hemodialysis patients who skipped more than one hour of the three times weekly
prescribed hemodialysis treatments in four months were at risk of poor outcomes.
Project Intervention
The DNP project was performed at the outpatient hemodialysis units. A
retrospective chart review was ascertained to find the patients who miss one or more of
the three times weekly hemodialysis treatments in four months. The data was placed on
the student investigator data collection tool. In addition, the patients who shortened
hemodialysis treatments by one or two hours of the hemodialysis treatments in four
months were placed on the student investigator data collection tool. The missed
hemodialysis treatments and partial treatments were obtained through the retrospective
chart review from the dialysis electronic medical record (D-EMR).
Positive PHQ-9 depression scores were obtained from the D-EMR. The Clinic
electronic medical record (C-EMR) was used to obtain previous depression measures.
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The variables were mediation, counseling, cognitive behavioral therapy, or no previous
depression treatment.
Therefore, the depression measures used for the depressed hemodialysis patients
who were non-compliant with hemodialysis treatments were placed on the Data
Collection Tool. Then, the depressed hemodialysis patient’s treatment compliance was
compared to the hemodialysis patients with no depression treatment. The data from the
retrospective chart review was compared to the data from patients who do not have
treatment for depression and miss or skip treatments. The DNP student was the only
investigator.
Population of Interest
The patient population inclusion criteria were any hemodialysis patient who
misses one or more of the required three times weekly hemodialysis treatments.
Additionally, patients who shortened their treatment by one or more hours in four months
were also in the inclusion criteria. The demographic information for the hemodialysis
population were patients ages from 18 to 90. Other data was any race, sex, or ethnic
group. The patient demographic data was included in the study. The patient’s identity and
the setting were deactivated.
Exclusion criteria for the DNP project included anyone under 18, any prisoners,
or non-English speakers. Patients who are vulnerable such as from nursing homes will
not be included. Finally, HIV patients were also excluded.
Measures: Data Collection
The DNP student researcher was the only investigator to obtain a retrospective
review on sixty patients. The depressed patient’s information was obtained for previous
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depression treatment. The variables were medication, counseling, cognitive behavior
therapy, and depression treatment. The variables were reviewed and added to the
practitioner-created data collection tool. The C-EMR was used to obtain medication
information. The D-EMR was used to obtain demographics such as patient age, race, and
ethnicity. Each patient had a separate data collection tool.
Analysis
The statistical method for the DNP project was quantitative and a t-test was used
to compare the depressed patients with the non-depressed patients. The data was
collected on each patient and documented on an individual data collection tool. The
student researcher compared depressed patients to non-depressed patients who miss two
or more of the three times weekly hemodialysis treatments or shorten one to two hours of
the hemodialysis treatments in four months. The data was collected and placed in an
Excel spreadsheet and the appropriate data was placed into the SPSS software to obtain
the statistical analysis.
The previous depressed measures were valid and reliable. The measures were
medication, counseling, and cognitive behavioral therapy. These variables were analyzed
using statistical analysis through the SPSS software. Therefore, the treatment variables
showed the types of therapy used and outcomes from the treatment.
Ethical Considerations
Patient safety was upheld by using the code of ethics to ensure the patients are not
harmed. The patient’s health information was kept safe and locked away to maintain
personal and health information. Both the C-EMR and the D-EMR were password
protected. The data was stored in a locked filing cabinet. Furthermore, the office door
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was locked, and the keys were with the investigator. Patient identity was deactivated. The
DNP researcher had the responsibility to uphold integrity and professionalism. As part of
the training for the research project, the researcher completed the Collaborative
Institutional Training Initiative program on human subjects.
Summary
Chapter II revealed a preview of the next steps for the DNP project. Measures and
variables were explained. The statistical method for the project was discussed. In
addition, the ethical treatment of the patients was outlined. The investigator explained
precautions for keeping patient health data safe.
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CHAPTER III – RESULTS
Introduction
The DNP project research did not begin until the Institutional Review Board
(IRB) Protocol # 22-085 at The University of Southern Mississippi provided the protocol
and nursing approval was granted for the project. The process steps to start were essential
to obtain the data needed. The first step was finding the patients with missed or partial
treatments through the retrospective chart review in the D-EMR. The amount of missed
and partial treatments was placed on the data collection tool.
The next step was placing the demographic data on the data collection tool. Then,
the previous depression measures were obtained from the C-EMR and placed on the data
collection tool. The data was then placed on the Excel spreadsheet The statistical analysis
was changed to the 2-step t-test using the SPSS software for correlation of the depressed
patients and the non-depressed patients.
After all the data was collected the next step was the evaluation of the results.
The demographic data revealed 29 males and 31female. Ethnicity was 46 black and 14
white.
Table 1
Sex of the Participants
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The average age of the participants was 56.5 with a minimum age of 33 while the
oldest was 85. The race demographic revealed 23.3% white participants and 76.7% black
participants. The depressed patients who missed hemodialysis treatments more than two
times and shortened the treatment one or more times in four months were 35%. The total
number of patients who were not depressed but missed or shortened their hemodialysis
treatments in four months was 65%.
Hence, the patients testing negative for depression were compared to the patients
who were not depressed. The results showed that the depressed patients were less likely
to miss the hemodialysis treatments than the patients who were not depressed. The
statistical analysis of the correlation is significant at the 0.05 level.
Table 2
Correlations
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Table 3
Depression Status of the Patients

The previous depression medication variables found in the retrospective chart
review revealed several different medications. The medications used were Bupropion,
Escitalopram, Sertraline, Paroxetine, Citalopram, and Venlafaxine. The medications used
more often were Sertraline and Bupropion. The counseling variable revealed six referrals
for counseling and one refusal for counseling.
The depression measure CBT was not found in the retrospective chart review. The
last variable was no depression treatment and the student investigator found three patients
that refused any treatment. Both the depressed patients and the non-depressed patients
missed hemodialysis treatments ranging from two to 20 times in four months.
Summary
The DNP project revealed unexpected results of the PICO. The results showed
opposite results of the PICO. The results may have been skewed due to the sample size.
The previous treatments measure results were expected. The medication variable results
showed multiple medications used to treat depression. The counseling variable revealed
six participants did have counseling for depression. In addition, cognitive behavior
therapy was not used and three people refused any depression treatment.
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CHAPTER IV – DISCUSSION
Introduction
The findings of the DNP Project were not expected. Out of the 60 patients
reviewed most of the patients were not depressed. The data revealed multiple missed
treatments for the hemodialysis population. The results of the project showed that
depressed patients were less likely to miss dialysis.
Strengths of the Project
One strength of the project was some hemodialysis patients agreed to take
medications for depression and a few patients did go to counseling. Another strength of
the project was the previous depression measures used for previous patients. The
medications and counseling were used more often to find the best evidence-based
interventions for change.
Interpretation
The statistical analysis of the project revealed depressed patients were less likely
to miss hemodialysis treatments than nondepressed. Depressed patients were more likely
to go to dialysis because of the depression treatment. Some of the patients were taking
medication or had counseling.
Limitations
One of the limitations was the small sample size. A larger sample of patients may
give a better answer. The retrospective chart review of missed treatments could also be
reviewed further back than four years.
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Implications for Future Practice
The study can be replicated with a larger sample size of 1,000 patients. The larger
sample size will reveal more data. More studies need to be performed to find the answer
for skipped and missed hemodialysis treatments in this population.
Conclusion
The purpose of the project was to find the answer to improve the overall health of
hemodialysis patients. Noncompliance with hemodialysis treatments leads to mortality
risk. In addition, this population of patients also misses blood pressure medications and
phosphorus binders. The noncompliance leads to complications such as hospital visits
and readmissions. Missing dialysis treatments may cause fluid overload, pulmonary
edema, elevated potassium, and anasarca. More studies can be done to find the answer to
improving compliance with hemodialysis.
Summary
The literature revealed information regarding depression and missed treatments in
multiple articles showing depression and depressive symptoms were in many of this
population. Other articles in the literature review discussed patients who refused
medication or treatment related to social determinants of health or culture. In addition,
treatment bias for this population may play a role in patients admitting depression or
depressive symptoms. The intervention for compliance was needed in this population of
patients who miss or skip part of the dialysis treatments to improve outcomes.
The project results were unexpected and need to be redone at a future date with a much
larger sample size. The larger sample size will give additional data for interpretation.
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Also, the investigator should add a variable for social determinants of health, cultural
needs, and socio-economic status in the data.

29

APPENDIX A – IRB Approval Letter
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APPENDIX B – Data Collection Tool
Identification #

Age

Sex

Race

PHQ-9 scores

Intervention 1 Medication

Intervention 2 Counseling

Intervention 3 Cognitive Behavioral Therapy

Intervention 4 No Treatment
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APPENDIX C – Medical Records Representation Dialysis
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APPENDIX D – Letters of Support
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